These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2343159)
101. Interventions targeted at women to encourage the uptake of cervical screening. Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000 [TBL] [Abstract][Full Text] [Related]
102. Targeting and tailoring message-framing: the moderating effect of racial identity on receptivity to colorectal cancer screening among African-Americans. Lucas T; Manning M; Hayman LW; Blessman J J Behav Med; 2018 Dec; 41(6):747-756. PubMed ID: 29882172 [TBL] [Abstract][Full Text] [Related]
103. Interventions targeted at women to encourage the uptake of cervical screening. Everett T; Bryant A; Griffin MF; Martin-Hirsch PP; Forbes CA; Jepson RG Cochrane Database Syst Rev; 2011 May; 2011(5):CD002834. PubMed ID: 21563135 [TBL] [Abstract][Full Text] [Related]
104. From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control. Miller SM; Mischel W; O'Leary A; Mills M Ann Behav Med; 1996; 18(4):219-28. PubMed ID: 18425667 [TBL] [Abstract][Full Text] [Related]
105. Interventions to improve follow-up of abnormal findings in cancer screening. Bastani R; Yabroff KR; Myers RE; Glenn B Cancer; 2004 Sep; 101(5 Suppl):1188-200. PubMed ID: 15316914 [TBL] [Abstract][Full Text] [Related]
106. Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature. Lester H; Wilson S Br J Gen Pract; 1999 Mar; 49(440):223-9. PubMed ID: 10343430 [TBL] [Abstract][Full Text] [Related]
108. Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages. Miller SM; Buzaglo JS; Simms SL; Green V; Bales C; Mangan CE; Sedlacek TV Ann Behav Med; 1999; 21(1):27-34. PubMed ID: 18425651 [TBL] [Abstract][Full Text] [Related]
109. Women's concerns about abnormal Papanicolaou test results. Lauver D; Rubin M J Obstet Gynecol Neonatal Nurs; 1991; 20(2):154-9. PubMed ID: 2030453 [TBL] [Abstract][Full Text] [Related]
110. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009]. Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201 [TBL] [Abstract][Full Text] [Related]
111. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. McKee MD; Lurio J; Marantz P; Burton W; Mulvihill M Arch Fam Med; 1999; 8(2):129-34. PubMed ID: 10101983 [TBL] [Abstract][Full Text] [Related]
112. Efforts to improve the follow-up of patients with abnormal Papanicolaou test results. Block B; Branham RA J Am Board Fam Pract; 1998; 11(1):1-11. PubMed ID: 9456441 [TBL] [Abstract][Full Text] [Related]
113. Message framing, dispositional optimism, and follow-up for abnormal Papanicolaou tests. Lauver D; Rubin M Res Nurs Health; 1990 Jun; 13(3):199-207. PubMed ID: 2343159 [TBL] [Abstract][Full Text] [Related]
114. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. Khanna N; Phillips MD J Am Board Fam Pract; 2001; 14(2):123-30. PubMed ID: 11314919 [TBL] [Abstract][Full Text] [Related]